Quinoxaline N , N ′-dioxide derivatives and related compounds as growth inhibitors of Trypanosoma cruzi . Structure–activity relationships
- 2 June 2004
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (14) , 3835-3839
- https://doi.org/10.1016/j.bmcl.2004.04.088
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Chemotherapy of Chagas Disease: Status and New DevelopmentsCurrent Topics in Medicinal Chemistry, 2002
- Enzymes of the Trypanothione Metabolism as Targets for Antitrypanosomal Drug DevelopmentCurrent Topics in Medicinal Chemistry, 2002
- Proteinases of Trypanosoma Cruzi: Potential Targets for the Chemotherapy of Chagas DiseaseCurrent Topics in Medicinal Chemistry, 2002
- Basic Cell Biology of Trypanosoma cruziCurrent Pharmaceutical Design, 2002
- The life cycle of Trypanosoma cruzi revisitedInternational Journal for Parasitology, 2001
- A potential target enzyme for trypanocidal drugs revealed by the crystal structure of NAD-dependent glycerol-3-phosphate dehydrogenase from Leishmania mexicanaStructure, 2000
- Trypanosoma cruzi: Characterization of an Intracellular Epimastigote-like FormExperimental Parasitology, 1999
- In vivo selection of a population of Trypanosoma cruzi and clones resistant to benznidazoleParasitology, 1998
- Detection of an ?epimastigote-like? intracellular stage ofTrypanosoma cruziZeitschrift Fur Parasitenkunde-Parasitology Research, 1995
- METABOLISM AND FUNCTIONS OF TRYPANOTHIONE IN THE KINETOPLASTIDAAnnual Review of Microbiology, 1992